HSD17B12 and neuroblastoma: The latest neuroblastoma GWAS, which included 2101 European‐American cases and 4202 controls, identified the genetic variant rs10742682 at the chr11p11.2 risk locus within the HSD17B12 gene as the most significant SNP associated with neuroblastoma risk (p‐value = 1.31 × 10−7; OR = 1.24, 95% CI: 1.15–1.34).[29] To identify SNPs with functional regulatory effects, we selected 42 SNPs within the chr11p11.2 locus that were in linkage disequilibrium (LD) (r2>0.8) with the index SNP rs10742682 (Figure1A).